Atara Biotherapeutics Executive Compensation Details
Ticker: ATRA · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 1604464
| Field | Detail |
|---|---|
| Company | Atara Biotherapeutics, INC. (ATRA) |
| Form Type | DEF 14A |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement, equity-awards
TL;DR
Atara Biotherapeutics DEF 14A out: Executive pay details for 2024, including equity awards for Nguyen & Touchon.
AI Summary
Atara Biotherapeutics, Inc. filed its DEF 14A on April 28, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on equity awards granted and vested to individuals such as Anh Co Nguyen and Pascal Touchon, with reported values for the covered years.
Why It Matters
This filing provides transparency into how Atara Biotherapeutics compensates its top executives, which can influence investor perception and corporate governance.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing disclosing executive compensation, not indicating new financial distress or significant operational changes.
Key Numbers
- 2024 — Fiscal Year (Compensation reporting period)
- 2023 — Fiscal Year (Prior year compensation data)
- 2022 — Fiscal Year (Prior year compensation data)
Key Players & Entities
- Atara Biotherapeutics, Inc. (company) — Filer
- Anh Co Nguyen (person) — Executive
- Pascal Touchon (person) — Executive
- 2024-12-31 (date) — Fiscal Year End
- 20250428 (date) — Filing Date
FAQ
What was the total compensation for Anh Co Nguyen in 2024?
The filing indicates equity awards granted and vested for Anh Co Nguyen during the covered year (2024), but specific dollar amounts for total compensation are not detailed in the provided excerpt.
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is filed by companies to solicit shareholder votes on important corporate matters, including the election of directors and executive compensation.
What specific types of equity awards are mentioned for Pascal Touchon?
The filing mentions 'VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember' and 'YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember' for Pascal Touchon, indicating granted and outstanding equity awards.
When is Atara Biotherapeutics' fiscal year end?
Atara Biotherapeutics' fiscal year ends on December 31st.
What is the filing date of this DEF 14A?
This DEF 14A filing was made on April 28, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 by Anh Co Nguyen regarding Atara Biotherapeutics, Inc. (ATRA).